基于CT的影像基因组学分析预测高危结肠癌(ATTRACT):一项多中心试验
ATTRACT多中心试验回顾性纳入300例非转移性结肠癌患者,按病理分期分为高危组与无风险组,由两名腹部放射科医师行临床-影像学评估,并对151例有基因组数据的患者构建影像组学模型。影像基因组学模型识别高危结肠癌的AUC为0.84,高于影像组学模型的0.74和放射科医师解读的0.58-0.82。
要点
- 影像基因组学模型识别高危结肠癌AUC 0.84,高于影像组学模型AUC 0.74。
- 影像基因组学模型敏感度88%、特异度63%、准确率84%。
- 两名放射科医师临床-影像学解读AUC分别为0.58和0.82。
核心结论
- 影像基因组学模型在识别高危结肠癌方面优于影像学解读和影像组学模型。
研究设计与样本
- ATTRACT为多中心试验(ClinicalTrials.gov NCT06108310),回顾性纳入300例非转移性结肠癌患者,由两名腹部放射科医师行影像学评估。
诊断标准与关键数值
- 两名放射科医师临床-影像学解读识别高危结肠癌的AUC为0.58-0.82(95%CI分别为0.52-0.63和0.76-0.85,P<0.001),敏感度67.9-93.8%,特异度47.4-68.4%,准确率65.3-90.7%。
- 模型1(临床-影像学加影像组学特征,300例)识别高危结肠癌AUC 0.74(95%CI 0.61-0.88,P<0.005),敏感度86%,特异度48%,准确率81%。
- 模型2(模型1加基因组学,151例)识别高危结肠癌AUC 0.84(95%CI 0.68-0.99,P<0.005),敏感度88%,特异度63%,准确率84%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Clinical staging on CT has several biases, and a radiogenomics approach could be proposed. The study aimed to test the performance of a radiogenomics approach in identifying high-risk colon cancer.
MATERIAL AND METHODS: ATTRACT is a multicentric trial, registered in ClinicalTrials.gov (NCT06108310). Three hundred non-metastatic colon cancer patients were retrospectively enrolled and divided into two groups, high-risk and no-risk, according to the pathological staging. Radiological evaluations were performed by two abdominal radiologists. For 151 patients, we achieved genomics. The baseline CT scans were used to evaluate the radiological assessment and to perform 3D cancer segmentation. One expert radiologist used open-source software to perform the volumetric cancer segmentations on baseline CT scans in the portal phase (3DSlicer v4.10.2). Implementing the classical LASSO with a machine-learning library method was used to select the optimal features to build Model 1 (clinical-radiological plus radiomic feature, 300 patients) and Model 2 (Model 1 plus genomics, 151 patients). The performance of clinical-radiological interpretation was assessed regarding the area under the curve (AUC), sensitivity, specificity, and accuracy. The average performance of Models 1 and 2 was also calculated.
RESULTS: In total, 262/300 were classified as high-risk and 38/300 as no-risk. Clinical-radiological interpretation by the two radiologists achieved an AUC of 0.58-0.82 (95% CI: 0.52-0.63 and 0.76-0.85, p < 0.001, respectively), sensitivity: 67.9-93.8%, specificity: 47.4-68.4%, and accuracy: 65.3-90.7%, respectively. Model 1 yielded AUC: 0.74 (95% CI: 0.61-0.88, p < 0.005), sensitivity: 86%, specificity: 48%, and accuracy: 81%. Model2 reached AUC: 0.84, (95% CI: 0.68-0.99, p < 0.005), sensitivity: 88%, specificity: 63%, and accuracy: 84%.
CONCLUSION: The radiogenomics model outperformed radiological interpretation in identifying high-risk colon cancer.
KEY POINTS: Question Can this radiogenomic model identify high-risk stages II and III colon cancer in a preoperative clinical setting? Findings This radiogenomics model outperformed both the radiomics and radiological interpretations, reducing the risk of improper staging and incorrect treatment options. Clinical relevance The radiogenomics model was demonstrated to be superior to radiological interpretation and radiomics in identifying high-risk colon cancer, and could therefore be promising in stratifying high-risk and low-risk patients.
引用
- Caruso D, Polici M, Zerunian M, et al. CT-based radiogenomic analysis to predict high-risk colon cancer (ATTRACT): a multicentric trial. Eur Radiol. 2025. PMID: 40471268. doi:10.1007/s00330-025-11728-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。